Factor | Univariable HR | p-value | Multivariable HRÂ (95% CI) | p-value |
---|---|---|---|---|
Monitoring randomisation | ||||
 LCM | 1.00 | - | 1.00 | - |
 CDM | 1.07 | 0.45 | 1.11 (0.93 - 1.35) | 0.25 |
Gender | ||||
 Male | 1.00 | - | 1.00 | - |
 Female | 0.80 | 0.02 | 0.79 (0.65 - 0.95) | 0.01 |
Initial ART | ||||
 TDF | 1.00 | <0.0001 | 1.00 | <0.0001 |
 NVP | 0.49 | - | 0.48 (0.38 - 0.62) | - |
 ABC | 1.18 | - | 1.27 (1.02 - 1.59) | - |
TB in 12Â months prior to enrolment | 1.13 | 0.26 | 1.07Â (0.86 - 1.33) | 0.52 |
Age (per 10Â years older) | 0.73 | <0.0001 | 0.73Â (0.64 - 0.84) | <0.0001 |
Baseline CD4 (per 100 cells/mm3 higher) | 0.60 | <0.0001 | 0.64Â (0.54 - 0.75) | <0.0001 |
Baseline viral load (log10 copies/mL) | 1.02 | 0.84 | 1.01Â (0.84 - 1.22) | 0.89 |
Adherence in previous 48Â weeksa (per 10% higher) | 0.89 | <0.0001 | 0.89Â (0.84 - 0.94) | <0.0001 |